Image

Use of Weightbearing Radiographs to Determine Treatment of bi- and Trimalleolar Ankle Fractures

Use of Weightbearing Radiographs to Determine Treatment of bi- and Trimalleolar Ankle Fractures

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

The aim of this study is to evaluate the outcomes after non-operative treatment of weightbearing stable bi-and trimalleolar ankle fractures.

Eligibility

Inclusion Criteria:

  • -With bi- and trimalleolar ankle fractures with less than 7 mm medial clear space on non-weightbearing radiographs that are deemed stable by weightbearing radiographs.
  • With type B medial malleolus fractures between the tip and the plafond and type C medial malleolus fractures at the level of the plafond (Herscovici classification). (6)
  • With fractures in the distal 1/3 of fibula (not-Maisonneuve)
  • Enabling stability evaluation within 14 days after injury
  • 18-75 years of age
  • with pre-injury walking ability without aids

Exclusion Criteria:

  • - With primary unstable ankle fractures, > 7mm medial clear space on primary radiographs
  • With fracture reduction prior to initial radiographic evaluation, open fracture, fractures resulting from high-energy trauma or multi trauma and pathological fracture
  • With type A medial malleolus avulsion fractures < 5mm (at the tip of the malleolus), that are not suitable for surgical intervention.
  • With Herscovici type D fractures, involving Lauge-Hansen SA2 fractures (supracollicular fracture - vertical, oblique or transverse direction of the plafond)
  • With displaced posterior malleolus fractures that needs fixation in the judgement of the attending surgeon
  • With neuropathies and symptomatic joint diseases such as Rheumatoid Arthritis
  • That are assumed not compliant (such as drug abuse, cognitive- and/or psychiatric disorders)
  • With previous history ipsilateral ankle fracture
  • With previous history ipsilateral major ankle-/foot surgery
  • Who live outside the hospital catchment areas not available to follow up
  • With insufficient Norwegian or English language skills
  • Non-compliant

Study details
    Ankle Fracture
    Bimalleolar
    Ankle Fracture
    Trimalleolar

NCT05765929

Ostfold Hospital Trust

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.